MediWound Ltd.

Mediwound Ltd.

Biotechnology Healthcare Yavne, Israel MDWD (NGM)

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has MediWound Ltd. had layoffs?
No layoff events have been recorded for MediWound Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does MediWound Ltd. have?
MediWound Ltd. has approximately 111 employees.
What industry is MediWound Ltd. in?
MediWound Ltd. operates in the Biotechnology industry, within the Healthcare sector.
Is MediWound Ltd. a publicly traded company?
Yes, MediWound Ltd. is publicly traded under the ticker symbol MDWD on the NGM. The company has a market capitalization of approximately $0.24 billion.
Where is MediWound Ltd. headquartered?
MediWound Ltd. is headquartered in Yavne, Israel at 42 Hayarkon Street, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.